Literature DB >> 33472033

siRNA Drugs: Here to Stay.

John J Rossi1, Daniel J Rossi2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33472033      PMCID： PMC7854346          DOI： 10.1016/j.ymthe.2021.01.015

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   12.910


× No keyword cloud information.
  7 in total

Review 1.  Delivery of Oligonucleotides to the Liver with GalNAc: From Research to Registered Therapeutic Drug.

Authors:  Alexandre J Debacker; Jon Voutila; Matthew Catley; David Blakey; Nagy Habib
Journal:  Mol Ther       Date:  2020-06-17       Impact factor: 11.454

Review 2.  Unlocking the potential of the human genome with RNA interference.

Authors:  Gregory J Hannon; John J Rossi
Journal:  Nature       Date:  2004-09-16       Impact factor: 49.962

Review 3.  Going beyond the liver: progress and challenges of targeted delivery of siRNA therapeutics.

Authors:  Cornelia Lorenzer; Mehrdad Dirin; Anna-Maria Winkler; Volker Baumann; Johannes Winkler
Journal:  J Control Release       Date:  2015-02-04       Impact factor: 9.776

4.  Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans.

Authors:  A Fire; S Xu; M K Montgomery; S A Kostas; S E Driver; C C Mello
Journal:  Nature       Date:  1998-02-19       Impact factor: 49.962

5.  Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells.

Authors:  S M Elbashir; J Harborth; W Lendeckel; A Yalcin; K Weber; T Tuschl
Journal:  Nature       Date:  2001-05-24       Impact factor: 49.962

6.  Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems.

Authors:  N J Caplen; S Parrish; F Imani; A Fire; R A Morgan
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-31       Impact factor: 11.205

7.  Gene silencing following siRNA delivery to skin via coated steel microneedles: In vitro and in vivo proof-of-concept.

Authors:  Rosalind H E Chong; Emilio Gonzalez-Gonzalez; Maria F Lara; Tycho J Speaker; Christopher H Contag; Roger L Kaspar; Sion A Coulman; Rachel Hargest; James C Birchall
Journal:  J Control Release       Date:  2013-01-08       Impact factor: 9.776
  7 in total
  8 in total

Review 1.  TRUE Gene Silencing.

Authors:  Masayuki Nashimoto
Journal:  Int J Mol Sci       Date:  2022-05-11       Impact factor: 6.208

2.  Therapeutic silencing of mTOR by systemically administered siRNA-loaded neutral liposomal nanoparticles inhibits DMBA-induced mammary carcinogenesis.

Authors:  Roja Sahu; Shakti Prasad Pattanayak; Shivesh Jha
Journal:  Br J Cancer       Date:  2022-10-19       Impact factor: 9.075

Review 3.  The Progress and Promise of RNA Medicine─An Arsenal of Targeted Treatments.

Authors:  Janet M Sasso; Barbara J B Ambrose; Rumiana Tenchov; Ruchira S Datta; Matthew T Basel; Robert K DeLong; Qiongqiong Angela Zhou
Journal:  J Med Chem       Date:  2022-05-09       Impact factor: 8.039

4.  DNA minicircles as novel STAT3 decoy oligodeoxynucleotides endowed with anticancer activity in triple-negative breast cancer.

Authors:  Geoffrey Casas; Federico Perche; Patrick Midoux; Chantal Pichon; Jean-Marc Malinge
Journal:  Mol Ther Nucleic Acids       Date:  2022-06-22       Impact factor: 10.183

5.  Therapeutic Silencing of BCL-2 Using NK Cell-Derived Exosomes as a Novel Therapeutic Approach in Breast Cancer.

Authors:  Kübra Kaban; Clemens Hinterleitner; Yanjun Zhou; Emine Salva; Ayse Gülten Kantarci; Helmut R Salih; Melanie Märklin
Journal:  Cancers (Basel)       Date:  2021-05-15       Impact factor: 6.639

6.  Utilizing RNA nanotechnology to construct negatively charged and ultrasound-responsive nanodroplets for targeted delivery of siRNA.

Authors:  Lu Guo; Dandan Shi; Mengmeng Shang; Xiao Sun; Dong Meng; Xinxin Liu; Xiaoying Zhou; Jie Li
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.419

7.  siRNA Transfection Mediated by Chitosan Microparticles for the Treatment of HIV-1 Infection of Human Cell Lines.

Authors:  Laura Chronopoulou; Francesca Falasca; Federica Di Fonzo; Ombretta Turriziani; Cleofe Palocci
Journal:  Materials (Basel)       Date:  2022-08-03       Impact factor: 3.748

Review 8.  The Fra-1/AP-1 Oncoprotein: From the "Undruggable" Transcription Factor to Therapeutic Targeting.

Authors:  Laura Casalino; Francesco Talotta; Amelia Cimmino; Pasquale Verde
Journal:  Cancers (Basel)       Date:  2022-03-14       Impact factor: 6.639
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.